Log in

Iradimed Stock Forecast, Price & News

-0.19 (-0.84 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $22.30
50-Day Range
MA: $21.92
52-Week Range
Now: $22.30
Volume62,015 shs
Average Volume48,996 shs
Market Capitalization$273.11 million
P/E Ratio51.86
Dividend YieldN/A
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also offers IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Read More
Iradimed logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.76 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:IRMD



Sales & Book Value

Annual Sales$38.52 million
Cash Flow$0.95 per share
Book Value$4.83 per share


Net Income$9.63 million


Market Cap$273.11 million
Next Earnings Date11/4/2020 (Estimated)
OptionableNot Optionable
-0.19 (-0.84 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IRMD News and Ratings via Email

Sign-up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Iradimed (NASDAQ:IRMD) Frequently Asked Questions

How has Iradimed's stock been impacted by COVID-19?

Iradimed's stock was trading at $22.51 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, IRMD shares have decreased by 0.9% and is now trading at $22.30.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Iradimed?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Iradimed in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Iradimed

When is Iradimed's next earnings date?

Iradimed is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Iradimed

How were Iradimed's earnings last quarter?

Iradimed Corp (NASDAQ:IRMD) posted its quarterly earnings data on Thursday, July, 30th. The medical equipment provider reported $0.05 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.07) by $0.12. The medical equipment provider earned $6.80 million during the quarter, compared to the consensus estimate of $5.53 million. Iradimed had a return on equity of 9.57% and a net margin of 14.74%.
View Iradimed's earnings history

What price target have analysts set for IRMD?

1 Wall Street analysts have issued twelve-month price objectives for Iradimed's shares. Their forecasts range from $26.00 to $26.00. On average, they expect Iradimed's share price to reach $26.00 in the next twelve months. This suggests a possible upside of 16.6% from the stock's current price.
View analysts' price targets for Iradimed

Who are some of Iradimed's key competitors?

What other stocks do shareholders of Iradimed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Iradimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Alphabet (GOOG), Mastercard (MA), Micron Technology (MU), Paypal (PYPL), Crispr Therapeutics (CRSP), IntriCon (IIN), QUALCOMM (QCOM) and Twitter (TWTR).

Who are Iradimed's key executives?

Iradimed's management team includes the following people:
  • Mr. Roger E. Susi, Founder, Chairman, CEO & Pres (Age 66)
  • Mr. Christopher K. Scott, CFO & Sec. (Age 49)
  • Mr. John McCreery, Chief Operating Officer (Age 64)
  • Mr. Brent Johnson, Exec. VP of Worldwide Sales & Marketing (Age 60)
  • Mr. Louis Waldman, Controller (Age 64)

What is Iradimed's stock symbol?

Iradimed trades on the NASDAQ under the ticker symbol "IRMD."

Who are Iradimed's major shareholders?

Iradimed's stock is owned by a number of institutional and retail investors. Top institutional investors include Russell Investments Group Ltd. (2.77%), RK Capital Management LLC (1.99%), Foundry Partners LLC (0.61%), Cadence Capital Management LLC (0.57%), WINTON GROUP Ltd (0.54%) and Bank of New York Mellon Corp (0.46%). Company insiders that own Iradimed stock include Anthony Vuoto, Brent Johnson, Louis S Waldman, Monty K Allen and Steven M Nardi.
View institutional ownership trends for Iradimed

Which institutional investors are selling Iradimed stock?

IRMD stock was sold by a variety of institutional investors in the last quarter, including Cadence Capital Management LLC, AQR Capital Management LLC, Stone Ridge Asset Management LLC, and UBS Group AG. Company insiders that have sold Iradimed company stock in the last year include Anthony Vuoto, Brent Johnson, Louis S Waldman, Monty K Allen, and Steven M Nardi.
View insider buying and selling activity for Iradimed

Which institutional investors are buying Iradimed stock?

IRMD stock was purchased by a variety of institutional investors in the last quarter, including Foundry Partners LLC, Assenagon Asset Management S.A., WINTON GROUP Ltd, RK Capital Management LLC, Russell Investments Group Ltd., Schonfeld Strategic Advisors LLC, Nuveen Asset Management LLC, and Bank of America Corp DE.
View insider buying and selling activity for Iradimed

How do I buy shares of Iradimed?

Shares of IRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Iradimed's stock price today?

One share of IRMD stock can currently be purchased for approximately $22.30.

How big of a company is Iradimed?

Iradimed has a market capitalization of $273.11 million and generates $38.52 million in revenue each year. The medical equipment provider earns $9.63 million in net income (profit) each year or $0.78 on an earnings per share basis. Iradimed employs 95 workers across the globe.

What is Iradimed's official website?

The official website for Iradimed is www.iradimed.com.

How can I contact Iradimed?

Iradimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The medical equipment provider can be reached via phone at 407-677-8022 or via email at [email protected]

This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.